drugset / Trial / NCT05478356

The Effects of Low-dose Atropine and Orthokeratology in Pediatric Myopia Control

NCT05478356

RandomizedParallel-groupDouble-blindTreatment

Summary

Both orthokeratology and atropine eye drops are effective methods for myopia control, but few studies have compared them all together simultaneously. Therefore, the primary aim of the present study was to compare the effect of orthokeratology versus low-dose (0.01% and 0.02%) atropine on the control of myopia progression.

Timeline

Start
2022-08-01
Primary completion
2023-08-31
Completion
2023-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 0.01 % Other
Comparator Atropine Other / unclassified 0.02 % Other

Indications